Pediatric forms of vasculitis

Gardner-Medwin, 2002, Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins, Lancet, 360, 1197, 10.1016/S0140-6736(02)11279-7

Baldursson, 1994, Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis, Arthritis Rheum, 37, 1007, 10.1002/art.1780370705

Rajala, 1993, Incidence and survival rate in cases of biopsy-proven temporal arteritis, Scand J Rheumatol, 22, 289, 10.3109/03009749309095141

Chun, 2001, The clinical and ocular manifestations of Takayasu arteritis, Retina, 21, 132, 10.1097/00006982-200104000-00006

Yang, 2005, A nationwide survey on epidemiological characteristics of childhood Henoch-Schonlein purpura in Taiwan, Rheumatology (Oxford), 44, 618, 10.1093/rheumatology/keh544

Piram, 2017, Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study, Rheumatology (Oxford), 56, 1358, 10.1093/rheumatology/kex158

Piram, 2013, Epidemiology of immunoglobulin A vasculitis (Henoch-Schonlein): current state of knowledge, Curr Opin Rheumatol, 25, 171, 10.1097/BOR.0b013e32835d8e2a

Kang, 2014, Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schonlein purpura, J Kor Med Sci, 29, 198, 10.3346/jkms.2014.29.2.198

Goldstein, 1992, Long-term follow-up of childhood Henoch-Schonlein nephritis, Lancet, 339, 280, 10.1016/0140-6736(92)91341-5

Pillebout, 2002, Henoch-Schonlein Purpura in adults: outcome and prognostic factors, J Am Soc Nephrol, 13, 1271, 10.1097/01.ASN.0000013883.99976.22

Shrestha, 2006, Henoch Schonlein purpura with nephritis in adults: adverse prognostic indicators in a UK population, QJM, 99, 253, 10.1093/qjmed/hcl034

Uppal, 2006, Henoch-Schonlein's purpura in adults versus children/adolescents: a comparative study, Clin Exp Rheumatol, 24, S26

Gibelin, 2011, Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement, Semin Respir Crit Care Med, 32, 264, 10.1055/s-0031-1279824

Zwerina, 2009, Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients, Semin Arthritis Rheum, 39, 108, 10.1016/j.semarthrit.2008.05.004

Iudici, 2016, Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis, Orphanet J Rare Dis, 11, 141, 10.1186/s13023-016-0523-y

Eleftheriou, 2013, Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years, Arthritis Rheum, 65, 2476, 10.1002/art.38024

Erden, 2017, Comparing polyarteritis nodosa in children and adults: a single center study, Int J Rheum Dis, 20, 1016, 10.1111/1756-185X.13120

McCrindle, 2017, Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for Health professionals from the American Heart association, Circulation, 135, e927, 10.1161/CIR.0000000000000484

Sarica, 1996, Juvenile Behcet's disease among 1784 Turkish Behcet's patients, Int J Dermatol, 35, 109, 10.1111/j.1365-4362.1996.tb03272.x

Ozen, 2002, The spectrum of vasculitis in children, Best Pract Res Clin Rheumatol, 16, 411, 10.1053/berh.2002.0237

Davatchi, 2010, Behcet's disease: from east to west, Clin Rheumatol, 29, 823, 10.1007/s10067-010-1430-6

Kotter, 2004, Behcet's disease in patients of German and Turkish origin living in Germany: a comparative analysis, J Rheumatol, 31, 133

Mohammad, 2013, Incidence, prevalence and clinical characteristics of Behcet's disease in southern Sweden, Rheumatology (Oxford), 52, 304, 10.1093/rheumatology/kes249

Olivieri, 2013, High prevalence of Behcet's disease in southern Italy, Clin Exp Rheumatol, 31, 28

Mahr, 2008, Population-based prevalence study of Behcet's disease: differences by ethnic origin and low variation by age at immigration, Arthritis Rheum, 58, 3951, 10.1002/art.24149

Karincaoglu, 2008, Demographic and clinical properties of juvenile-onset Behcet's disease: a controlled multicenter study, J Am Acad Dermatol, 58, 579, 10.1016/j.jaad.2007.10.452

Kim, 1994, Clinical analysis of 40 cases of childhood-onset Behcet's disease, Pediatr Dermatol, 11, 95, 10.1111/j.1525-1470.1994.tb00559.x

Kone-Paut, 2011, Registries in rheumatological and musculoskeletal conditions. Paediatric Behcet's disease: an international cohort study of 110 patients. One-year follow-up data, Rheumatology (Oxford), 50, 184, 10.1093/rheumatology/keq324

Kone-Paut, 1998, Clinical features of Behcet's disease in children: an international collaborative study of 86 cases, J Pediatr, 132, 721, 10.1016/S0022-3476(98)70368-3

Krause, 1999, Childhood Behcet's disease: clinical features and comparison with adult-onset disease, Rheumatology (Oxford), 38, 457, 10.1093/rheumatology/38.5.457

Pivetti-Pezzi, 1995, Behcets disease in children, Jpn J Ophthalmol, 39, 309

Bloch, 1990, The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods, Arthritis Rheum, 33, 1068, 10.1002/art.1780330803

Hunder, 1990, The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction, Arthritis Rheum, 33, 1065, 10.1002/art.1780330802

Ruperto, 2010, EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: overall methodology and clinical characterisation, Ann Rheum Dis, 69, 790, 10.1136/ard.2009.116624

Kone-Paut, 2016, Consensus classification criteria for paediatric Behcet's disease from a prospective observational cohort: PEDBD, Ann Rheum Dis, 75, 958, 10.1136/annrheumdis-2015-208491

Batu, 2017, The performance of different classification criteria in paediatric Behcet's disease, Clin Exp Rheumatol, 108, 119

Dolezalova, 2013, Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS), Ann Rheum Dis, 72, 1628, 10.1136/annrheumdis-2012-202111

Exley, 1997, Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides, Arthritis Rheum, 40, 371, 10.1002/art.1780400222

Jauhola, 2010, Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children, Arch Dis Child, 95, 877, 10.1136/adc.2009.182394

Ozen, 2004, Juvenile polyarteritis: results of a multicenter survey of 110 children, J Pediatr, 145, 517, 10.1016/j.jpeds.2004.06.046

Guillevin, 2011, The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort, Medicine (Baltimore), 90, 19, 10.1097/MD.0b013e318205a4c6

Lin, 2015, Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous gamma-immunoglobulin therapy, Arch Dis Child, 100, 542, 10.1136/archdischild-2014-306427

Chartapisak, 2009, Prevention and treatment of renal disease in Henoch-Schonlein purpura: a systematic review, Arch Dis Child, 94, 132, 10.1136/adc.2008.141820

Kobayashi, 2006, Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease, Circulation, 113, 2606, 10.1161/CIRCULATIONAHA.105.592865

Sano, 2007, Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment, Eur J Pediatr, 166, 131, 10.1007/s00431-006-0223-z

Berdej-Szczot, 2017, Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease, Kardiol Pol, 75, 261, 10.5603/KP.a2016.0179

Davies, 2015, Predicting IVIG resistance in UK Kawasaki disease, Arch Dis Child, 100, 366, 10.1136/archdischild-2014-307397

Mukhtyar, 2009, EULAR recommendations for the management of primary small and medium vessel vasculitis, Ann Rheum Dis, 68, 310, 10.1136/ard.2008.088096

Mukhtyar, 2009, EULAR recommendations for the management of large vessel vasculitis, Ann Rheum Dis, 68, 318, 10.1136/ard.2008.088351

Navon Elkan, 2014, Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy, N Engl J Med, 370, 921, 10.1056/NEJMoa1307362

Zhou, 2014, Early-onset stroke and vasculopathy associated with mutations in ADA2, N Engl J Med, 370, 911, 10.1056/NEJMoa1307361

Caorsi, 2016, Monogenic polyarteritis: the lesson of ADA2 deficiency, Pediatr Rheumatol Online J, 14, 51, 10.1186/s12969-016-0111-7

Sanchez, 2018, JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies, J Clin Invest, 128, 3041, 10.1172/JCI98814

Zhou, 2016, Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease, Nat Genet, 48, 67, 10.1038/ng.3459

Ohnishi, 2017, A Japanese family case with juvenile onset Behcet's disease caused by TNFAIP3 mutation, Allergol Int, 66, 146, 10.1016/j.alit.2016.06.006

Aeschlimann, 2018, A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease, Ann Rheum Dis, 77, 728, 10.1136/annrheumdis-2017-212403

Filiz, 2014, Cutaneous leukocytoclastic vasculitis due to Salmonella enteritidis in a child with interleukin-12 receptor beta-1 deficiency, Pediatr Dermatol, 31, 236, 10.1111/j.1525-1470.2012.01856.x

Conyers, 2016, Successful second bone marrow transplantation in a Wiskott-Aldrich syndrome patient with systemic vasculitis, J Allergy Clin Immunol, 137, 1615, 10.1016/j.jaci.2015.11.008

Taşkıran, 2017, Hypomorphic RAG1 defect in a child presented with pulmonary hemorrhage and digital necrosis, Clin Immunol, 187, 92, 10.1016/j.clim.2017.10.010

Morishita, 2012, Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions, J Rheumatol, 39, 2012, 10.3899/jrheum.120299